NCT06617754Active, not recruiting
International Severe CRSwNP Registry 2024-2028
InternatioNal seVerE CRSwNP Registry (INVENT) 2024-2028
Source: ClinicalTrials.gov · Last updated 8 Apr 2025
Brief summary (registry, in English)
The objective of the study is to collect real-life data worldwide, which already have been collected in national databases, to merge the data and the knowledge with the focus of better care for the individual patients, more efficient use of the hospital cost of biologics and working for "personalized medicine".
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 26 Sept 2024
- Start date
- 31 Mar 2025
- Primary completion date
- Jan 2030
- Lead sponsor
- Vibeke Backer
- Diseases
- Asthma
- NCT number
- NCT06617754
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 31 Mar 2025 to the primary completion date, Jan 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unilateral polyps
- Non-Type-2 inflammation
- Treatment less than 6 months
Who the study is looking for
- Symptoms of CRSwNP
- Indication for biologic treatment as suggested by EPOS/EUFOREA
- Have been followed for 6 months
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Rhinolaryngology Head & Neck surgery and Audiology Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.